Clinical Pharmacist Anticoagulant Stewardship
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03527615|
Recruitment Status : Recruiting
First Posted : May 17, 2018
Last Update Posted : May 17, 2018
|Condition or disease||Intervention/treatment|
|Safety Issues Anticoagulant Toxicity||Other: Clinical Pharmacist Medication Review|
|Study Type :||Observational|
|Estimated Enrollment :||4000 participants|
|Official Title:||Clinical Pharmacist Led Hospital-Wide Direct Oral Anticoagulant Stewardship Program|
|Actual Study Start Date :||January 1, 2017|
|Estimated Primary Completion Date :||January 1, 2020|
|Estimated Study Completion Date :||January 1, 2020|
- Other: Clinical Pharmacist Medication Review
Programmatic review of physician orders for direct anticoagulants by clinical pharmacists.
- Percent of clinical pharmacist consultations accepted by attending physician. [ Time Frame: At forty-eight months ]Calculated by dividing the number of clinical pharmacist consultations accepted, by the number of clinical pharmacist consultations given, during the period. Data for consultation counts will be obtained from patient electronic medical record.
- Percent of clinical pharmacist consultations accepted by attending physician. [ Time Frame: At six months ]Calculated by dividing the number of clinical pharmacist consultations accepted, by the number of clinical pharmacist consultations given, during the period. Data for consultation counts will be obtained from patient electronic medical record.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03527615
|Contact: Amichai Perlman, Pharmdemail@example.com|
|Hadassah Medical Organization, Jerusalem, Israel||Recruiting|
|Contact: Hadas Lemberg, PhD 00 972 2 6777572 firstname.lastname@example.org|
|Sub-Investigator: Amichai Perlman, PharmD|
|Principal Investigator: Mordechai Muszkat, MD|
|Principal Investigator:||Mordechai Muszkat, MD||Hadassah University Medical Center|